Inventor · disambiguated record
Lucas D. Bondurant
Also filed as: BONDURANT LUCAS · BONDURANT LUCAS D
3 granted patents·6 pending applications·7 citations·filing 2021–2024
59Inventor score
Files withALNYLAM PHARMACEUTICALS INC9
Top patents by PatentIndex Score
9 records- 0187US11613751B2Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Mar 28, 2023·6 cites·30 claims
- 0284US11162103B2Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Nov 2, 2021·1 cites·23 claims
- 0375US12416006B2Cell death-inducing DFFA-like effector B (CIDEB) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Sep 16, 2025·0 cites·23 claims
- 0466US2024360455A1Extra-hepatic delivery irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0565US2025034567A1Cell death-inducing dffa-like effector b (cideb) irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0662US2024067972A1Dipeptidyl peptidase 4 (dpp4) irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0755US2025283071A1Modified double stranded oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0855US2023332147A1Irna compositions and methods for silencing growth factor receptor bound protein 10 (grb10) or growth factor receptor bound protein 14 (grb14) in the liverALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0951US2023203496A1Sirna compositions and methods for silencing gpam (glycerol-3-phosphate acyltransferase 1, mitochondrial) expressionALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lucas D. Bondurant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →